Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001044321-09-000114
Filing Date
2009-05-01
Accepted
2009-05-01 16:49:41
Documents
1
Period of Report
2009-04-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7223
  Complete submission text file 0001044321-09-000114.txt   9283
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Reporting) CIK: 0001044321 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29173 | Film No.: 09790113

Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617 674 5300
VERENIUM CORP (Issuer) CIK: 0001049210 (see all company filings)

EIN.: 223297375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals